Back to all funds
PPFAS Mutual FundPharmaVery High Risk
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth
Current NAV₹10.81as of 30/5/2026
AUM4932.00 Cr
AUM
4932.00 Cr
Expense Ratio
1.95%
Min SIP
₹500
Min Lumpsum
₹1000
Launch Date
3 April 2006
Exit Load
Nil
Riskometer
LowModerateHighVery High
Risk Level: Very High
Volatility: 16.04 | Sharpe Ratio:
Fund Manager & Key Metrics
Fund ManagerRajeev Thakkar(3.5 years yrs)
Volatility16.04
Portfolio Turnover54%
BenchmarkNifty Pharma TRI
Holdings Date25/5/2026
Asset Allocation
Equity: 96.00% | T-Bills: 4.00%
Investment Objective
Aims to provide capital appreciation by investing in Pharma securities
Top Holdings
As of 25-May-2026
1. Sun Pharmaceutical Industries Ltd.20.5%
2. Dr. Reddy's Laboratories Ltd.12.8%
3. Cipla Ltd.10.4%
4. Divi's Laboratories Ltd.9.8%
5. Torrent Pharmaceuticals Ltd.7.2%
6. Aurobindo Pharma Ltd.5.8%
7. Alkem Laboratories Ltd.5.2%
8. Lupin Ltd.4.9%
9. Ipca Laboratories Ltd.3.8%
10. Mankind Pharma Ltd.3.5%
Overview
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth overview and fund details
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth ek specialist fund hai jo pharmaceuticals ke sector mein invest karta hai. Iska objective hai ki investors ko long-term capital appreciation provide kare. Ye fund un logon ke liye suitable hai jo equity mutual funds mein investment karna chahte hain aur unhe pharmaceutical sector ki growth potential pe vishwas hai. Ye fund PPFAS Mutual Fund ke under aata hai, jinki track record kaafi achi hai. Investment style mein active management hai jahan fund manager stocks select karte hain based on research aur analysis. Agar aap ek aise investor hain jo high growth potential aur long-term wealth creation ki talash mein hain, toh yeh fund aapke liye ek achha option ho sakta hai.Performance & Analysis
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth yearly return performance
Ab baat karte hain PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth ke yearly returns ki. Pehle toh, is fund ki 1 saal ke returns ka data available nahi hai. Lekin, jab hum 3 saal aur 5 saal ki performance ki baat karte hain, toh yeh bhi nahi diya gaya hai. Yeh fund abhi naya hai aur abhi tak consistent returns provide nahi kar paaya hai. Iski comparison benchmark, Nifty Pharma TRI se karte hain, jo ki pharma sector ka ek reliable benchmark hai. Fund manager Rajeev Thakkar ka tenure ab 3.5 saal hai, aur unka expertise is fund ke performance mein kuch impact daal sakta hai. Lekin, fund ki volatility bhi high hai, jo ki investor ko dhyan mein rakhni chahiye. Kya aapko lagta hai ki yeh fund long-term mein achha return generate karega? Ye toh dekhte hain, lekin jo log equity mutual funds mein long-term SIP investing karna chahte hain, unke liye yeh fund ek option ho sakta hai. Lekin, jab bhi aap invest karein, toh market volatility ko samajhna na bhooliye.PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth portfolio breakdown for investors
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth ki portfolio breakdown par nazar daalte hain. Is fund ke top 5 holdings yeh hain: 1. Sun Pharmaceutical Industries Ltd. - 20.5% 2. Dr. Reddy's Laboratories Ltd. - 12.8% 3. Cipla Ltd. - 10.4% 4. Divi's Laboratories Ltd. - 9.8% 5. Torrent Pharmaceuticals Ltd. - 7.2% Is fund ka sector allocation kaafi focused hai sirf pharma sector par, jo ki un investors ke liye achha hai jo is sector ki growth potential pe vishwas rakhte hain. Ye fund actively manage kiya jata hai taaki portfolio diversification achieve kiya ja sake. Agar aapne socha hoga ki aapke portfolio mein kya hona chahiye, toh ye fund aapke liye ek accha addition ho sakta hai agar aap pharma sector mein growth dekh rahe hain.PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth risk analysis and volatility
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth ka riskometer 'Very High' hai, jo ki signifies karta hai ki is fund ka investment risk bhi kaafi high hai. Yeh fund un logon ke liye suitable nahi hai jo risk-averse hain. Investors ko ye samajhna hoga ki pharmaceutical sector mein volatility kaafi zyada hoti hai, aur iske sath sath Sharpe ratio ka data available nahi hai. Lekin historically, high-growth mutual funds mein investment karne se returns bhi substantial ho sakte hain agar aap long-term ki soch rakhte hain. Isliye, agar aap risk le sakte hain aur aapka investment horizon long-term hai, toh yeh fund aapke liye achha rahega.Who Should Invest?
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth long term investment outlook
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth ka long-term investment outlook kuch important trends par depend karta hai. Agar hum historical positioning ki baat karein, toh pharmaceutical sector ne recently growth dekhi hai due to increased health awareness aur advancements in medical technology. Updated in May 2026, yeh fund aise investors ke liye achha ho sakta hai jo pharmaceutical stocks mein interested hain. Historical data suggest karta hai ki agar aap is sector mein investment rakhte hain, toh aapko higher returns milne ki sambhavna hai, lekin risk ka scenario bhi saath mein hai. Kya aap is sector ki opportunities ko capitalise karne ke liye tayyar hain? Yeh fund un investors ke liye long-term mein faydemand ho sakta hai jo sector ki growth potential dekhte hain.Pros & Cons
PPFAS Mutual Fund Pharma Fund - Regular Plan - Growth – fayde aur nuksan
- High growth potential in pharmaceutical sector
- Active management by experienced fund manager
- Focused investment strategy
- Portfolio diversification benefits
- High risk and volatility
- No historical return data available
- Expense ratio is relatively high at 1.95%
Frequently Asked Questions
Returns
Returns
| Period | Fund Return (%) | Benchmark (Nifty Pharma TRI) (%) |
|---|---|---|
| 1 Year | N/A | — |
| 3 Years | N/A | — |
| 5 Years | N/A | — |
| Since Launch | 0.2% | — |
SIP Calculator
SIP / Lumpsum Calculator
Based on fund's 1Y return of 12.0%
Invested: ₹956k
Gains: ₹15642k
Total Invested
₹956245.48
Total Returns
+ ₹15641892.92
Maturity Value
₹16598138.40
SIP of ₹5000 for 10 years (stepping up 10% annually), then held for 20 years at 12.0% p.a.
*Projected returns are for illustration only. Past performance does not guarantee future returns.
Similar Funds
Related Funds in Pharma
Compare with Alternatives
Disclaimer: Mutual fund investments are subject to market risks. Please read all scheme‑related documents carefully before investing. Past performance does not guarantee future returns. The content on this page is for educational purposes only.